Actively Recruiting
Treatment of Post COVID Syndrome Using Variable Pulse Transcranial Magnetic Stimulation with Personalized EEG-Based Parameters
Led by Mayo Clinic · Updated on 2026-08-19
40
Participants Needed
1
Research Sites
12 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the use of Variable Pulse Transcranial Magnetic Stimulation TMS to improve symptoms in patients with Post COVID Syndrome PCS, a condition affecting individuals after COVID-19 infection, characterized by symptoms such as loss of smell anosmia, ringing in the ears tinnitus, and fatigue. The study is designed to test whether this brain stimulation technique can result in measurable improvements in these symptoms. The study involves administering the Electromagnetic Brain Pulsing Variable Pulse Protocol EMBP via an FDA-approved TMS device. Participants will receive one 30-minute TMS session per day, five days a week Monday through Friday, for either 2 or 4 weeks, depending on the study group. Baseline EEG results will be used to personalize TMS parameters for each participant. During the study, participants will be assessed at various times using tests such as the University of Pennsylvania Smell Identification Test UPSIT, the Tinnitus Handicap Inventory, and the Modified Fatigue Impact Scale to monitor changes. Additional measures include anxiety, depression, global health scores, EEG alpha wave characteristics, and monitoring for any serious adverse events over two years. The study will last up to 12 weeks for primary outcomes, with longer-term safety monitored.
CONDITIONS
Brief Title
Post COVID-19 Syndrome Treatment With Variable Pulse Transcranial Magnetic Stimulation
Research Team
D
Department of Medicine Research Hub, Coordinator
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here